Review: taking Alphagan and Hctz together


Summary

Drug interactions are reported among people who take Alphagan and Hctz together. This review analyzes the effectiveness and drug interactions between Alphagan and Hctz. It is created by eHealthMe based on reports of 353 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Alphagan

Alphagan has active ingredients of brimonidine tartrate. It is often used in glaucoma. (latest outcomes from Alphagan 5,255 users)

Hctz

Hctz has active ingredients of hydrochlorothiazide. It is often used in high blood pressure. (latest outcomes from Hctz 8,378 users)

On Sep, 21, 2016

353 people who take Alphagan, Hctz are studied.


Number of reports submitted per year:

Alphagan and Hctz drug interactions.

Drug effectiveness over time:

Alphagan:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Hctz:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Alphagan:
  • female: 33.0% - (1 of 3 people)
  • male: 0.0% - (0 of 1 people)
Hctz:
  • female: 100.0% - (1 of 1 people)
  • male: 0.0% - (0 of 1 people)

Drug effectiveness by age:

Alphagan:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 33.0% - (1 of 3 people)
Hctz:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • renal failure acute
  • syncope
  • mental status changes
  • renal tubular necrosis
  • sepsis syndrome
  • erythema
  • feeling hot
  • blister
  • dermatitis contact
  • dry skin
1 - 6 months:
  • erythema
  • burning sensation
  • fatigue
  • rhinorrhoea
  • vision blurred
  • abdominal pain upper
  • amnesia
  • anxiety
  • asthenia
  • asthma
6 - 12 months:
  • body temperature increased
  • dermatitis contact
  • emotional distress
  • erythema
  • eye swelling
  • insomnia
  • ocular hyperaemia
  • rash
  • rebound effect
  • skin burning sensation
1 - 2 years:
  • fatigue
  • lymphocyte count decreased
  • pruritus
  • anorectal discomfort
  • dizziness
  • dysgeusia
  • dyspnoea
  • fall
  • cataract
  • chromatopsia
5 - 10 years:
  • arthropathy
  • cardiac murmur
  • dizziness
  • emotional distress
  • hypertension
  • mental disorder
  • pulmonary embolism
  • tinnitus
not specified:
  • dyspnoea
  • asthenia
  • oedema peripheral
  • erythema
  • pain
  • pneumonia
  • dizziness
  • vision blurred
  • malaise
  • drug ineffective

Most common drug interactions by gender *:

female:
  • dyspnoea
  • erythema
  • vision blurred
  • oedema peripheral
  • pain
  • asthenia
  • fatigue
  • vomiting
  • hypertension
  • malaise
male:
  • intraocular pressure increased
  • dizziness
  • dyspnoea
  • asthenia
  • drug ineffective
  • pneumonia
  • syncope
  • weight decreased
  • blood urea increased
  • eye pain

Most common drug interactions by age *:

30-39:
  • erythema
  • drug effect decreased
  • feeling hot
  • rebound effect
40-49:
  • erythema
  • pain
  • skin discolouration
  • anxiety
  • hyperkeratosis
  • burning sensation
  • hypertension
  • blister
  • deep vein thrombosis
  • dysgeusia
50-59:
  • dizziness
  • weight increased
  • blindness unilateral
  • blood cholesterol increased
  • drug ineffective
  • dyspnoea
  • eye pain
  • headache
  • optic atrophy
  • optic ischaemic neuropathy
60+:
  • dyspnoea
  • asthenia
  • vision blurred
  • pneumonia
  • loss of consciousness
  • vomiting
  • syncope
  • insomnia
  • dizziness
  • oedema peripheral

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Alphagan and Hctz?

Can you answer these questions?

More questions for: Alphagan, Hctz

You may be interested in these reviews

More reviews for: Alphagan, Hctz

On eHealthMe, Alphagan (brimonidine tartrate) is often used to treat glaucoma. Hctz (hydrochlorothiazide) is often used to treat high blood pressure. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.